BioCentury | Jul 14, 2020
Deals

July 13 Quick Takes: Spudich, Rutter to lead start-up Kainomyx; plus deals for Ovid-Angelini, Dewpoint-Merck and Kiadis-Sanofi

...Spudich, Rutter to lead start-up focused on parasitic diseases Kainomyx Inc. emerged from stealth Monday to discover...
...for two other preclinical programs. BioCentury Staff gaboxadol (OV101) Cytokinetics Inc. Merck & Co. Inc. Dewpoint Therapeutics Ovid Therapeutics Inc. Angelini Sanofi Kiadis Pharma N.V. Kainomyx Inc....
Items per page:
1 - 1 of 1
BioCentury | Jul 14, 2020
Deals

July 13 Quick Takes: Spudich, Rutter to lead start-up Kainomyx; plus deals for Ovid-Angelini, Dewpoint-Merck and Kiadis-Sanofi

...Spudich, Rutter to lead start-up focused on parasitic diseases Kainomyx Inc. emerged from stealth Monday to discover...
...for two other preclinical programs. BioCentury Staff gaboxadol (OV101) Cytokinetics Inc. Merck & Co. Inc. Dewpoint Therapeutics Ovid Therapeutics Inc. Angelini Sanofi Kiadis Pharma N.V. Kainomyx Inc....
Items per page:
1 - 1 of 1